BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19190330)

  • 1. Human renal cancer cells express a novel membrane-bound interleukin-15 that induces, in response to the soluble interleukin-15 receptor alpha chain, epithelial-to-mesenchymal transition.
    Khawam K; Giron-Michel J; Gu Y; Perier A; Giuliani M; Caignard A; Devocelle A; Ferrini S; Fabbi M; Charpentier B; Ludwig A; Chouaib S; Azzarone B; Eid P
    Cancer Res; 2009 Feb; 69(4):1561-9. PubMed ID: 19190330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-15 is a major regulator of the cell-microenvironment interactions in human renal cancer.
    Giron-Michel J; Azzi S; Khawam K; Caignard A; Devocelle A; Perrier A; Chouaib S; Eid P; Azzarone B
    Bull Cancer; 2011 May; 98(5):32-9. PubMed ID: 21609895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial-mesenchymal transition in renal cell carcinoma cells.
    Chuang MJ; Sun KH; Tang SJ; Deng MW; Wu YH; Sung JS; Cha TL; Sun GH
    Cancer Sci; 2008 May; 99(5):905-13. PubMed ID: 18294286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane-bound interleukin (IL)-15 on renal tumor cells rescues natural killer cells from IL-2 starvation-induced apoptosis.
    Wittnebel S; Da Rocha S; Giron-Michel J; Jalil A; Opolon P; Escudier B; Validire P; Khawam K; Chouaib S; Azzarone B; Caignard A
    Cancer Res; 2007 Jun; 67(12):5594-9. PubMed ID: 17575122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Renal Normal, Tumoral, and Cancer Stem Cells Express Membrane-Bound Interleukin-15 Isoforms Displaying Different Functions.
    Azzi S; Gallerne C; Romei C; Le Coz V; Gangemi R; Khawam K; Devocelle A; Gu Y; Bruno S; Ferrini S; Chouaib S; Eid P; Azzarone B; Giron-Michel J
    Neoplasia; 2015 Jun; 17(6):509-17. PubMed ID: 26152359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cells express a functional interleukin-15 receptor.
    Tejman-Yarden N; Zlotnik M; Lewis E; Etzion O; Chaimovitz C; Douvdevani A
    Nephrol Dial Transplant; 2005 Mar; 20(3):516-23. PubMed ID: 15671076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.
    Doucet C; Meazza R; Pottin-Clemenceau C; Scudeletti M; Brouty-Boye D; Ferrini S; Alileche A; Taoufik Y; Jasmin C; Azzarone B; Indiveri F
    Melanoma Res; 1997 Aug; 7 Suppl 2():S7-17. PubMed ID: 9578412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.
    Obiri NI; Hillman GG; Haas GP; Sud S; Puri RK
    J Clin Invest; 1993 Jan; 91(1):88-93. PubMed ID: 8423237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmembrane-Bound IL-15-Promoted Epithelial-Mesenchymal Transition in Renal Cancer Cells Requires the Src-Dependent Akt/GSK-3β/β-Catenin Pathway.
    Yuan H; Meng X; Guo W; Cai P; Li W; Li Q; Wang W; Sun Y; Xu Q; Gu Y
    Neoplasia; 2015 May; 17(5):410-20. PubMed ID: 26025664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells.
    Ghoul A; Serova M; Astorgues-Xerri L; Bieche I; Bousquet G; Varna M; Vidaud M; Phillips E; Weill S; Benhadji KA; Lokiec F; Cvitkovic E; Faivre S; Raymond E
    Cancer Res; 2009 May; 69(10):4260-9. PubMed ID: 19417139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostaining of interleukin-4 receptor on human renal cell carcinoma.
    Varricchio F; Obiri NI; Haas GP; Puri RK
    Lymphokine Cytokine Res; 1993 Dec; 12(6):465-9. PubMed ID: 8123763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs.
    Frankenberger B; Pohla H; Noessner E; Willimsky G; Papier B; Pezzutto A; Kopp J; Oberneder R; Blankenstein T; Schendel DJ
    Clin Cancer Res; 2005 Mar; 11(5):1733-42. PubMed ID: 15755994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of interleukin-4 receptors expressed on human renal cell carcinoma cells.
    Obiri NI; Puri RK
    Oncol Res; 1994; 6(9):419-27. PubMed ID: 7703528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juxtacrine function of interleukin-15/interleukin-15 receptor system in tumour derived human B-cell lines.
    Tsukamoto K; Huang YC; Dorsey WC; Carns B; Sharma V
    Clin Exp Immunol; 2006 Dec; 146(3):559-66. PubMed ID: 17100778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated circulating levels of soluble interleukin-1 receptor type II during interleukin-2 immunotherapy.
    Vannier E; Kaser A; Atkins MB; Fantuzzi G; Dinarello CA; Mier JW; Tilg H
    Eur Cytokine Netw; 1999 Mar; 10(1):37-42. PubMed ID: 10210771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epithelial-mesenchymal transition in cancer progression].
    Gos M; Miłoszewska J; Przybyszewska M
    Postepy Biochem; 2009; 55(2):121-8. PubMed ID: 19824467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-15 is a major regulator of the cell-microenvironment interactions in human renal homeostasis.
    Giron-Michel J; Azzi S; Ferrini S; Chouaib S; Camussi G; Eid P; Azzarone B
    Cytokine Growth Factor Rev; 2013 Feb; 24(1):13-22. PubMed ID: 22981349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs.
    Morandi B; Mortara L; Carrega P; Cantoni C; Costa G; Accolla RS; Mingari MC; Ferrini S; Moretta L; Ferlazzo G
    Int Immunol; 2009 May; 21(5):599-606. PubMed ID: 19325034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vgamma9Vdelta2 T cells from renal cell carcinoma patients.
    Viey E; Lucas C; Romagne F; Escudier B; Chouaib S; Caignard A
    J Immunother; 2008 Apr; 31(3):313-23. PubMed ID: 18317356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenic properties of renal cell carcinoma and the pathogenesis of osteolytic bone metastases.
    Perut F; Cenni E; Unger RE; Kirkpatrick CJ; Giunti A; Baldini N
    Int J Oncol; 2009 May; 34(5):1387-93. PubMed ID: 19360351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.